A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer

Journal of Cancer Science and Therapy

Volumn 5, Issue 10, 2013, Pages 320-324

  Hejazi, Jalal ^a   Rastmanesh, Reza ^a   Taleban, Forough Azam ^a   Molana, Seyed Hadi ^b   Ehtejab, Golamreza ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Armey Medical Sciences University   (Iran)

Author keywords

Curcumin; Prostate cancer; Quality of life; Radioprotective

Indexed keywords

CURCUMIN; PLACEBO;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; EXTERNAL BEAM RADIOTHERAPY; HISTOLOGY; HUMAN; HUMAN TISSUE; LOWER URINARY TRACT SYMPTOM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION PROTECTION; RANDOMIZED CONTROLLED TRIAL;

EID: 84889654408     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000222     Document Type: Article

References (24)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, et al. (2009) Cancer incidence and mortality in Iran. Ann Oncol 20: 556-563.
3. Sadjadi A, Nooraie M, Ghorbani A, Alimohammadian M, Zahedi MJ, et al. (2007) The incidence of prostate cancer in Iran: results of a population-based cancer registry. Arch Iran Med 10: 481-485.
4. Nilsson S, Norlén BJ, Widmark A (2004) A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 43: 316-381.
5. Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, et al. (2008) Management of complications of prostate cancer treatment. CA Cancer J Clin 58: 196-213.
6. Wahlgren T, Brandberg Y, Häggarth L, Hellström M, Nilsson S (2004) Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with< sup> 192 ir brachytherapy: A prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25. Int J Radiat Oncol Biol Phys 60: 51-59.
7. Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, et al. (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70: 1124-1129.
8. Garg AK, Buchholz TA, Aggarwal BB (2005) Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 7: 1630-1647.
9. Akpolat M, Kanter M, Uzal MC (2009) Protective effects of curcumin against gamma radiation-induced ileal mucosal damage. Arch Toxicol 83: 609-617.
10. Aravindan N, Madhusoodhanan R, Ahmad S, Johnson D, Herman T (2008) Curcumin inhibits NFkappaB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol Ther 7: 569-576.
11. Khafif A, Hurst R, Kyker K, Fliss DM, Gil Z, et al. (2005) Curcumin: a new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132: 317-321.
12. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F (2010) Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr 13: 654-662.
13. Pérez-Jiménez J, Neveu V, Vos F, Scalbert A (2010) Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the phenol-explorer database. J Agric Food Chem 58: 4959-4969.
14. van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, et al. (2008) An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 44: 2418-2424.
15. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM (2004) Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23: 1599-1607.
16. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, et al. (2008) A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin. Indian J Pharm Sci 70: 445-449.
17. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, et al. (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900.
18. Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP, et al. (2013) Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients. Radiat Res 180: 34-43.
19. Goel A, Aggarwal BB (2010) Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 62: 919-930.
20. Okunieff P, Xu J, Hu D, Liu W, Zhang L, et al. (2006) Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys 65: 890-898.
21. Jagetia GC (2007) Radioprotection and radiosensitization by curcumin. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease: Springer: 301-320.
22. Bhojani N, Capitanio U, Suardi N, Jeldres C, Isbarn H, Shariat SF, et al. (2010) The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys 76: 342-348.
23. Fuchs-Tarlovsky V (2012) Role of antioxidants in cancer therapy. Nutrition 29: 15-21.
24. Margalit DN, Kasperzyk JL, Martin NE, Sesso HD, Gaziano JM, Ma J, et al. (2012) Beta-carotene Antioxidant Use During Radiation Therapy and Prostate Cancer Outcome in the Physicians' Health Study. Int J Radiat Oncol Biol Phys 83: 28-32.